Yahoo Finance

FDA Clears CardioComm Solutions’ GUAVA II ECG Viewer with ECG Acquisition, Analysis, Interpretation, and Reporting Capabilities as a Class II Medical Device

TORONTO, ONTARIO / ACCESSWIRE / CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram ("ECG") acquisition and management ...
Business Wire

Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...
Benzinga.com

HeartBeam (NASDAQ: BEAT) Recognized as a Top Global Innovator in Portable ECG Technology

The company was ranked second worldwide out of 243 companies evaluated in 12-lead ECG innovation in PatentVest’s “Total Cardiac Intelligence” report. HeartBeam’s ranking underscores the rapid ...
USA Today

HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Business Wire

Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in collaboration with Mayo Clinic, today announced U.S. Food and Drug ...